WE

Wei Ren

  • CIK: 0002123015
  • EIN:
  • Business address:

Information

  • Mailing address
    C/O ASCENTAGE PHARMA GROUP INC., 700 KING FARM BLVD., SUITE 510, ROCKVILLE, MD, 20850
  • Phone
    N/A
  • State location
    N/A
  • State of incorporation
    N/A
  • Fiscal year end
    N/A
  • SIC
    N/A
  • Filings
    N/A

About Wei Ren

Wei Ren (CIK: 0002123015) is an American company incorporated in the state of N/A. Head office is located at . Work in the industry N/A. Wei Ren is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Wei Ren

Filings Format Description Filed/Effective File/Film Number
3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001213900-26-033135 (34 Act) Size: 0 KB		 Mar-23-2026

001-42484

26783832

Recent 20 filings. View all Wei Ren filings

Reviews

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Frequently Asked Questions

Tags:

  • Wei Ren overview
  • Wei Ren job
  • Wei Ren stock
  • Wei Ren ownership
  • Wei Ren CEO
  • Wei Ren documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Zuddio Maximiliano
Update: Mar 27, 2026
ZHU SHUNYAN
Update: Mar 27, 2026
Zheng Jing
Update: Mar 27, 2026
Yulo Marriana Henares
Update: Mar 27, 2026
Yu Zhenghua
Update: Mar 27, 2026
Yu Wei
Update: Mar 27, 2026

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2886 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3804 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1300 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1551 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4592 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2065 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4240 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1187 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4191 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by